We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

A lit light bulb.

Exposure to Higher Levels of Light Increases Cognitive Performance

Cells in cell culture.

AI Model Creates Realistic Images of Single Cells

Broken eggshells.

Researchers Develop Bioplastic From Eggshells as Sustainable Alternative to Plastic

Plastic Food Packaging May Contain Harmful Chemicals That Affect Hormones and Metabolism

Male Spear Squids' Birthdays Affect Their Mating Styles

No Adverse Health Risks From Steroids Used for Pre-Term Birth, Study Finds

News

How Bacteria Control Their Size

By monitoring thousands of individual bacteria scientists discovered how they maintain their size from generation to generation.

Bristol-Myers Squibb and Calibr Collaborate

Collaboration and license agreement focused on new treatment approaches for fibrotic diseases.

Quickly Tracing The Source Of Tainted Food

Technology can trace contaminated food to its source.

Gilead Sciences Announces Acquisition of Phenex’s FXR Program

Gilead will acquire Farnesoid X Receptor program for the treatment of liver diseases including nonalcoholic steatohepatitis (NASH).

Pfizer Acquires Redvax

Acquisition provides Pfizer with a preclinical CMV vaccine candidate.

SK Capital Makes Strategic Investment in Halo Pharmaceutical

Company partners with Halo Pharmaceutical to support their growth with additional resources and capital.

Saint-Gobain Announces Agreement with Argos Therapeutics

Collaboration will support commercial production of Argos immunotherapies based on the Arcelis® technology platform.

NIH Teams with Industry to Develop Treatments for Niemann-Pick Type C Disease

Vtesse plans to collaborate with NICHD to launch a second clinical study of cyclodextrin for the treatment of NPC.

Remapping the damaged brain

Scientists at the RIKEN Center for Life Science Technologies, along with researchers from the AIST Human Technology Research Institute in Japan, have identified a time-dependent interplay between two brain regions that contributes to the recovery of motor function after focal brain damage, such as a stroke.

BioLineRx Completes Dose Escalation Stage of Phase 1 Trial for Stem Cell Mobilization

Results of Phase 1 trial for BL-8040 expected in Q1 2015.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter